Spinal cord stimulation for neuropathic pain.

Area of Science:

• Neurology
• Pain Management
• Neurosurgery

Background:

• Spinal cord stimulation (SCS) has been a treatment for localized chronic neuropathic pain for over 40 years.
• Common indications include complex regional pain syndrome (CRPS), failed back surgery syndrome (FBSS), and peripheral neuropathy.
• Traditional SCS efficacy is sometimes limited by paresthesias, affecting blinded evaluations and placebo effects.

Purpose of the Study:

• To review the efficacy and safety of spinal cord stimulation for chronic neuropathic pain.
• To evaluate the impact of new SCS technologies on pain management.
• To assess the risk/benefit ratio of SCS in refractory pain conditions.

Main Methods:

• Review of randomized controlled trials (RCTs) and retrospective studies on SCS.
• Comparison of conventional tonic SCS with newer stimulation waveforms (burst, high-frequency, closed-loop).
• Evaluation of SCS efficacy in CRPS, FBSS, and painful diabetic neuropathy.

Main Results:

• RCTs show SCS superiority over physiotherapy alone in CRPS and over reoperation/conventional medical treatment (CMM) in FBSS.
• Newer SCS modalities appear as effective as, or slightly superior to, conventional SCS in FBSS, potentially reducing paresthesias.
• SCS demonstrated efficacy in painful diabetic neuropathy compared to CMM.
• Complications are common but generally not serious, supporting a favorable risk/benefit profile.

Conclusions:

• Spinal cord stimulation is a valuable treatment option for medically refractory chronic neuropathic pain, particularly for FBSS and CRPS.
• Emerging SCS technologies offer potential advantages in patient comfort and pain relief.
• Despite frequent, minor complications, SCS provides a favorable risk/benefit ratio for patients resistant to other therapies.